Post Profile






Related Posts


AstraZeneca plc (ADR) (AZN), Actavis Inc (ACT): Can Fish Oil Help This Drug Giant Regain its Mojo?

Business & Finance / Investing : Insider Monkey

AstraZeneca plc (ADR) (NYSE:AZN)’s financial results have been on a downward spiral lately, as patent expirations have led to sharp declines in sales of its leading drugs. In 2012, the company lost $4.5 billion of sales due to exclu...

AstraZeneca plc (ADR) (AZN): Is This Purchase a Game-Changer?

Business & Finance / Investing : Insider Monkey

London-based pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN) recently announced that it had agreed to purchase U.S.-based lung-drug manufacturer Pearl Therapeutics for at least $1.1 billion. The private firm is noted for its n...

Amarin Corporation plc (ADR) (AMRN): AstraZeneca plc (ADR) (AZN) is Headed in the Right Direction

Business & Finance / Investing : Insider Monkey

In my last report on AstraZeneca plc (ADR) (NYSE:AZN), I focused on the patent expiry of Seroquel IR and the resultant decline in company sales. According to recent news, the troubles of AstraZeneca are still not over and the compan...

AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY): 2 Keys to Success for This Diabetes Drug’s Second Chance

Business & Finance / Investing : Insider Monkey

If at first you don’t succeed, try, try again. We’ve heard that old saw many times, but it’s good advice. It’s also advice that two big pharmaceutical companies are heeding. AstraZeneca plc (ADR) (NYSE:AZN) and Bristol Myers Squibb ...

AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): A Big Pharma Company With a Juicy Dividend Yield and Low Valuation

Business & Finance / Investing : Insider Monkey

Recently, AstraZeneca plc (ADR) (NYSE:AZN) announced that it has agreed to acquire Pearl Therapeutics, the respiratory drug manufacturer, in a transaction worth around $1.15 billion. Since the beginning of the year, AstraZeneca plc ...

Comments


Copyright © 2016 Regator, LLC